Healthcare Triangle, Inc.
HCTI NasdaqΒ· Services-Computer Integrated Systems Design
Last close Β· Oct 23, 2026
$0.34
KIRA Β· Stoqlyβs AI analyst, in plain words
- Healthcare Triangle, Inc. had $13.9M of revenue in fiscal 2025, up 18.8% on the year before. Over five years, revenue changed β15.0% a year on average.
- Its operating margin was β70.5%, down 29.8Β pts: of every 100 in sales, about β70 is left after running the business.
- Healthcare Triangle, Inc. lost $9.5M in fiscal 2025.
- Free cash flow was β$16.5M in fiscal 2025, β119.0% of revenue.
- Healthcare Triangle, Inc. owes $3.1M more than it holds in cash.
Market cap
$0.9M
P/E
β
Revenue
$13.9M
Net income
β$9.5M
Free cash flow
β$16.5M
Operating margin
β70.5%
Healthcare Triangle, Inc. in 30 seconds Β· fiscal 2025
Are sales growing?
+18.8%
Yes. Sales grew 18.8% last year.
Does it make a profit?
β68.2%
No. It lost money last year.
Does profit turn into cash?
β119.0%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Healthcare Triangle, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Apr 15, 2026
- Legal name
- Healthcare Triangle, Inc.
- CIK
- 0001839285
Healthcare Triangle, Inc. Β· HCTI
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $35.3M | $45.9M | $33.2M | $11.7M | $13.9M |
| Revenue growth | 12.5% | 30.1% | β27.6% | β64.8% | 18.8% |
| Net interest income | β$0.6M | β$0.2M | β$1.0M | β$1.2M | β$0.6M |
| Gross margin | 29.8% | 24.6% | 3,222.6% | 9,148.4% | 8,890.6% |
| Operating margin | β15.2% | β35.6% | β23.2% | β40.6% | β70.5% |
| Net income | β$5.9M | β$14.4M | β$8.7M | β$6.0M | β$9.5M |
| Net margin | β16.9% | β31.3% | β26.2% | β51.0% | β68.2% |
| Diluted EPS | β$0.20 | β$3.88 | β$2.08 | β$16,909.30 | β$152.30 |
| Cash | |||||
| Cash from operations | β$7.1M | β$5.4M | β$2.2M | β$1.1M | β$16.5M |
| Capital expenditure | β | $0.0M | $0.0M | β | $0.0M |
| Free cash flow | β | β$5.4M | β$2.2M | β | β$16.5M |
| FCF margin | β | β11.8% | β6.5% | β | β119.0% |
| Share buybacks | β | $0.1M | β | β | β |
| Share count change | 5.5% | β87.4% | 13.0% | β100.0% | 15,375.0% |
| Debt and strength | |||||
| Cash and short-term investments | $1.8M | $1.3M | $1.2M | $0.0M | $7.6M |
| Debt incl. finance leases | $2.2M | $2.7M | $4.7M | $2.7M | $10.7M |
| Shareholders' equity | $14.2M | $6.0M | $0.5M | β$5.1M | $9.9M |
| Current ratio | 1.9x | 1.2x | 0.7x | 0.2x | 1.0x |
| Interest coverage | β9.4x | β77.0x | β7.9x | β | β17.3x |
| Returns and quality | |||||
| Return on capital | β28.8% | β174.6% | β152.7% | β | β59.2% |
| Return on equity | β64.1% | β141.6% | β264.1% | β | β392.4% |
| Return on tangible equity | β238.6% | β2,155.9% | β | β | 225.0% |
| Piotroski F-score | 2 | 3 | 3 | 4 | 3 |
| Altman Z'' | 1.4 | β11.3 | β23.0 | β91.7 | β8.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Healthcare Triangle, Inc. Β· HCTI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.34 a share, the company is worth $0.9M.
Source: SEC EDGAR XBRL filings (CIK 0001839285). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
